ACCESS Newswire
22 Jan 2020, 03:07 GMT+10
VANCOUVER, BC AND BOSTON, MA / ACCESSWIRE / January 21, 2020 / Imagin Medical Inc. (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) ('Imagin' or the 'Company') today announced that, further to its press release of January 7, 2020, the Company has closed its non-brokered private placement (the 'Offering'), issuing 38,280,000 units ('Units') at $0.05 per Unit for proceeds of $1,914,000.
Each Unit consists of one common share ('Share') and one Share purchase warrant ('Warrant'), each Warrant entitling the holder to acquire one additional Share at $0.15 for a period of 24 months, provided that in the event the closing price of the Company's Shares is equal to or greater than $0.25 per Share for 10 consecutive trading days, the Company may, by notice to the Warrant holders (which notice may be by way of general news release), reduce the remaining exercise period of the Warrants to not less than 30 days following the date of such notice.
Total finders' fees will be paid in the form of cash in the amount of $52,790 and 1,055,800 finders' warrants (exercisable at $0.05 per Share for 24 months).
All securities issued will be subject to a four-month hold period.
The net proceeds of the Offering will be used for the continued development of the i/Blue™ Imaging System, management of the U.S. Food and Drug Administration ('FDA') approval process for i/Blue, and general working capital.
'The success of this offering strengthens lmagin's financial position at an important time as we continue to drive our i/Blue technology to the marketplace,' said Jim Hutchens, lmagin's President and CEO. 'We appreciate our investors' confidence.'
About Imagin Medical
Imagin Medical is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures. The Company believes its first product, the i/Blue™ Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to reduce recurrence rates. The Company's initial focus is bladder cancer. Learn more at www.imaginmedical.com.
Forward-Looking Statements
Information set forth in this news release contains forward-looking statements. These statements reflect management's current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Specifically, there is no assurance the Company's imaging system will work in the manner expected. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information. The CSE has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.
Contacts:
Stephen Kilmer, Investor Relations
Telephone: 647-872-4849
Email: [email protected]
Jim Hutchens, President & CEO
Telephone: 833-246-2446
SOURCE: Imagin Medical
Get a daily dose of Raleigh Times news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Raleigh Times.
More InformationPARIS, France: French farmers brought traffic to a crawl around Paris and gathered outside the National Assembly on May 26, using their...
HANOI, Vietnam: Amid shifting global trade dynamics and growing concerns over U.S. tariffs, France and Vietnam have signed more than...
NEW YORK, New York - U.S. stocks were weaker Wednesday, following Tuesday's heady gains when the Dow Jones jumped 741 points. Bond...
SAO PAULO, Brazil: Amid a surge in electric vehicle (EV) adoption and growing competition in Brazil, Chinese automaker GAC has officially...
CHICAGO, Illinois: McDonald's is closing its experimental beverage spinoff, CosMc's, less than two years after launching the standalone...
BEIJING, China: China's Lenovo reported a steep 64 percent drop in fourth-quarter profit, falling significantly short of analyst expectations...
WASHINGTON, DC - U.S. President Donald Trump on Monday said he believed God was behind his election loss in 2020, even though he has...
BRUSSELS, Belgium: U.S. drugmakers are charging significantly more for new treatments, particularly those targeting rare diseases,...
(Photo credit: Mark J. Rebilas-Imagn Images) CONCORD, N.C. -- This time, Corey Heim didn't just slam the door on his NASCAR CRAFTSMAN...
ABU DHABI, 16th May, 2025 (WAM) -- Etihad Airways has announced a new addition to its growing US network with the launch of non-stop...
State action to reduce carbon emissions and address climate change can make a big difference, even in the absence of a strong federal...
The San Francisco 49ers today announced they have signed PThomas Morsteadand LBChazz Surrattto one-year deals. In order to make room...